Promo - Lung Cancer Therapeutics Market

Lung Cancer Therapeutics Market to expand into varied untapped markets globally, says
Market Data Forecast
The Global Lung Cancer Therapeutics Market was worth $5.65 billion in 2016 and estimated to
be growing at a CAGR of 6.7%, to reach $7.81 billion by 2021.
The global Lung Cancer Therapeutics Market is expected to have a high growth rate and
approach $7.81 billion by 2021, says a report by Market Data Forecast, Inc. The rising proportion
of smoking population and pollution are the key projected drivers behind the growth.
Introduction of scientifically advanced new treatments is also expected to drive forward the
market growth globally. Invention of safer and novel could increase the scope of the market
widely, and into still untapped markets around the world.
The availability of advanced radiation treatment facilities and superior priced drugs in the market
in the future is supposed to increase the market share globally. In the present day, cigarette
smoking is projected to be the key driver behind the increase in the occurrence of lung cancer,
which subsequently increases the market share.
In the U.S., lung cancer is currently the most occurring cancer among the population, and is
again reasoned with the rising proportion of smoking population. Various reimbursement
schemes by governments also propel the market growth forward. Though, the availability of
generic drugs at subsidised rates is predicted to constrain the growth of the market.
Browse full research report with TOC on " Lung Cancer Therapeutics Market by Treatment Type
(Chemotherapy (Cisplatin, Taxol, Navelbine, Camptosar and Alimta), Radiotherapy (External
Beam, Internal Beam and Systemic) and Other Drugs (Abraxane, Avastin, Crizotinib, Docetaxel
and Gefitinib)) and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and
Forecasts (2016–2021)" at:
Market Data Forecast has segmented the global lung cancer therapeutics market on the basis of
treatment type:
Treatment Type (Volume, Kilograms; Revenue, USD Thousands; 2016-2021)
Chemotherapy Radiotherapy Other Drugs
Further Key Findings From the Report Suggest:
Poor treatment facilities in the emerging and developing countries around the globe is a
key restraint to the market growth.
North America and Europe lead the lung cancer therapeutics market globally, owing to
the high occurrence of smoking population.
High treatment costs and adverse effects of radiation treatments also deter the growth of
the market.
Asia-Pacific region to have a high growth rate due to the increasing pollution because of
the presence of large number of developing countries and the subsequent
Browse related reports by Market Data Forecast:
Colorectal Cancer Market –
Read Our Blog By Market Data Forecast:
About Market Data Forecast
Being a familiar face to the Fortune 500 companies in the field of market research, Market Data
Forecast provides its clientele with research material through syndicated reports, consult projects
and industry newsletters across various domains and verticals. Our in-house research panel,
comprises of industry experts, vertical/domain specialists, supported by a well-built research &
data models that help in providing insights for making well-informed decisions. We have a well-
established data gathering network across 100+ countries through tie-ups and collaboration’s
with the key personnel in value chains & local research organizations. Apart the excellent
research services, we also boast of unique post-purchase services offering a 24*7 analyst
support for the period of six months. Further, though a continuous feedback from our users,
clients and experts, we keep on innovating ourselves in this field to support the organizations in
the most efficient ways.
Contact Info:
Name: Mr. Abhishek Shukla
Email: [email protected]
Organization: MarketDataForecast™
Address: 2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
Phone: +1-888-702-9626
Email: [email protected]

The Global Lung Cancer Therapeutics Market was worth $5.65 billion in 2016 and estimated to be growing at a CAGR of 6.7%, to reach $7.81 billion by 2021.